Featured Stories

Atrial fibrillation (AF) is a common heart rhythm disorder affecting millions of people worldwide. In Europe alone, over 6 million individuals live with this condition. AF can significantly...

Following treatment with TheraSphere Y90 Glass Microspheres then surgery, Griffiths is back to enjoying life again.

While heart disease is often perceived as a male health issue, it is a significant health concern for women in Europe as well. Indeed, women are at a higher risk for specific types of heart...

Survey among 3,000 people with chronic pain in Germany, Italy, and the United Kingdom underscores the mental and emotional challenges faced by those living with the condition. With one in five...

Boston Scientific has announced the appointment of Angelo Auricchio, M.D., Ph. D., as chief medical officer (CMO) of the Rhythm Management business in Europe, Middle East, and Africa (EMEA). A...